Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 5/20 | 0.55 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.55 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.55 |
| ▸ | LPL | P06858 | 3/20 | 0.51 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.51 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | MEF2D | Q14814 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5253068 | 0.88 | S1PR1 (0.54) | S1PR1S1PR4S1PR5LPLLIPG | |
| SCHEMBL11410042 | 0.86 | S1PR1 (0.53) | S1PR1S1PR4S1PR5LPLLIPG | |
| SCHEMBL1068395 | 0.86 | S1PR1 (0.53) | S1PR1S1PR4S1PR5LPLLIPG | |
| SCHEMBL15946031 | 0.84 | HDAC4 (0.48) | S1PR1S1PR4S1PR5LPLLIPG | |
| SCHEMBL29767685 | 0.84 | LPL (0.56) | S1PR1S1PR4S1PR5LPLLIPG | |
| SCHEMBL9418466 | 0.84 | LPL (0.56) | S1PR1S1PR4S1PR5LPLLIPG | |
| SCHEMBL11871771 | 0.84 | LPL (0.56) | S1PR1S1PR4S1PR5LPLLIPG | |
| SCHEMBL10793241 | 0.82 | LPL (0.51) | S1PR1S1PR4S1PR5LPLLIPG | |
| SCHEMBL18631859 | 0.82 | HDAC4 (0.49) | S1PR1S1PR4S1PR5LPLLIPG | |
| SCHEMBL9298052 | 0.81 | PPARA (0.57) | S1PR1S1PR4S1PR5LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7767858-B2 | Diimines and secondary diamines | ALBEMARLE CORPORATION (US) | 2010-08-03 | — | — | US | disclosed |
| US-20080194788-A1 | Diimines and Secondary Diamines | ALBEMARLE CORPORATION (US) | 2008-08-14 | — | — | US | disclosed |
| US-20080033210-A1 | DIIMINES AND SECONDARY DIAMINES | ALBEMARLE CORPORATION (US) | 2008-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080033210-A1 | DIIMINES AND SECONDARY DIAMINES | DDT, DDC, AOC1 | S1PR1 3862/4885S1PR4 4324/4885S1PR5 4033/4885 |
| US-20080194788-A1 | Diimines and Secondary Diamines | DDT, DDC, AOC1 | S1PR1 3780/4885S1PR4 4239/4885S1PR5 3794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.